Get the Stockscreener App
40.70
4.52%
1.76
Bruker Corp stock is traded at $40.70, with a volume of 3.14M.
It is up +4.52% in the last 24 hours and up +20.63% over the past month.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
See More
Previous Close:
$38.94
Open:
$40.07
24h Volume:
3.14M
Relative Volume:
1.37
Market Cap:
$6.20B
Revenue:
$3.44B
Net Income/Loss:
$-8.30M
P/E Ratio:
-273.71
EPS:
-0.1487
Net Cash Flow:
$43.30M
1W Performance:
+8.27%
1M Performance:
+20.63%
6M Performance:
+10.06%
1Y Performance:
+12.18%
1-Day Range:
$39.66
$40.72
1-Week Range:
$37.44
$40.78
52-Week Range:
$28.53
$56.22
Bruker Corp Stock (BRKR) Company Profile
Name
Bruker Corp
Sector
Industry
Phone
978663-3660
Address
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
40.70 | 5.93B | 3.44B | -8.30M | 43.30M | -0.1487 |
ABT
Abbott Laboratories
|
96.81 | 165.90B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
343.32 | 129.59B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.19 | 109.96B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.23 | 94.25B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.99 | 45.58B | 6.07B | 1.06B | 1.34B | 1.8063 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-09-25 | Initiated | Goldman | Sell |
| Nov-20-25 | Initiated | Rothschild & Co Redburn | Buy |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-10-24 | Initiated | UBS | Neutral |
| Dec-05-24 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-24 | Initiated | Barclays | Overweight |
| Sep-30-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Feb-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-21-22 | Initiated | UBS | Buy |
| Aug-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jun-15-21 | Upgrade | Cleveland Research | Neutral → Buy |
| Feb-05-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-02-20 | Initiated | Goldman | Sell |
| Nov-16-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-01-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Apr-02-20 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Apr-01-20 | Downgrade | Needham | Strong Buy → Hold |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Upgrade | Goldman | Sell → Neutral |
| Jun-24-19 | Reiterated | Needham | Strong Buy |
| Jun-21-19 | Reiterated | BofA/Merrill | Neutral |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| May-06-19 | Reiterated | Needham | Strong Buy |
| May-03-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-03-19 | Upgrade | UBS | Sell → Neutral |
| Apr-12-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-12-19 | Reiterated | BTIG Research | Buy |
| Jan-03-19 | Initiated | Needham | Strong Buy |
View All
Bruker Corp Stock (BRKR) Latest News
Bruker (BRKR) Unveils Innovations for Cancer Research at Upcomin - GuruFocus
A Look at Bruker Corp (BRKR) After 4.5% Gain -- GF Value $71.47 vs Price $40.70 - GuruFocus
Bruker Launches MyGenius PRO Automated Molecular Diagnostics System in Europe - Contract Pharma
Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026 - 富途牛牛
Bruker unveils spatial biology workflows, opens PaintScape pre-orders - Investing.com
Bruker ties cancer research platforms together with new 208-plex data - Stock Titan
Bruker expands microbiology portfolio with new testing tools - Investing.com
Bruker launches automated molecular diagnostics system in Europe - Investing.com
Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management - Yahoo Finance
Bruker Corporation (NASDAQ:BRKR) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Mark Munch Sells 2,000 Shares of Bruker (NASDAQ:BRKR) Stock - MarketBeat
Bruker (BRKR) EVP Mark Munch sells 2,000 shares after option exercise - Stock Titan
BRKR (NASDAQ: BRKR) director sale notice — 2,000 shares via option - Stock Titan
Bruker (NASDAQ:BRKR) Upgraded at TD Cowen - MarketBeat
BRKR SEC FilingsBruker Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Bruker Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Barclays Maintains Bruker Corp(BRKR.US) With Buy Rating, Cuts Target Price to $45 - 富途牛牛
Bruker Corp. Opens with 6.41% Gain, Marking Significant Gap Up in Stock Performance - Markets Mojo
Why Bruker (BRKR) Stock Is Up Today - Yahoo Finance
Bruker (BRKR) Unveils Innovative NMR Products at Experimental Co - GuruFocus
Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026 - Eagle-Tribune
Bruker Corp (BSP:B2RK34) Stock News, Headlines & Updates - GuruFocus
Bruker Corporation 8-K SEC Filing: Company Details, Key Identifiers, and Listing Information (April 10, 2026) 2122 - Minichart
[ARS] BRUKER CORP SEC Filing - Stock Titan
Bruker (NASDAQ: BRKR) sets 2026 virtual meeting, pay and auditor votes - Stock Titan
Bruker Corp (BRKR) director Bernard Thierry listed in Form 3 filing - Stock Titan
Bruker (BRKR) BioSpin president to exit with $1.02M separation deal - Stock Titan
Bruker (BSP:B2RK34) Cyclically Adjusted Price-to-FCF : (As of Apr. 17, 2026) - GuruFocus
Bruker Corporation (BRKR) stock price, news, quote and history - Yahoo Finance UK
Bruker (BSP:B2RK34) Change In Other Working Capital : R$0 Mil (TTM As of Dec. 2025) - GuruFocus
Bruker (BSP:B2RK34) Sale Of Property, Plant, Equipment : R$0 Mil (TTM As of Dec. 2025) - GuruFocus
Bruker (BSP:B2RK34) Change In Prepaid Assets : R$0 Mil (TTM As of Dec. 2025) - GuruFocus
Bruker (BSP:B2RK34) Purchase Of Investment : R$0 Mil (TTM As of Dec. 2025) - GuruFocus
Bruker (BSP:B2RK34) Construction In Progress : R$0 Mil (As of Dec. 2025) - GuruFocus
Bruker (BSP:B2RK34) Asset Impairment Charge : R$0 Mil (TTM As of Dec. 2025) - GuruFocus
Bruker Corp (BSP:B2RK34) Valuation: Significantly Undervalued - GuruFocus
Bruker (BSP:B2RK34) Net Income (Discontinued Operations) : R$0 Mil (TTM As of Dec. 2025) - GuruFocus
Bruker Corp Stock Historical Valuations - GuruFocus
Bruker Corp Stock Intrinsic Values - GuruFocus
Bruker (BSP:B2RK34) Shiller PE Ratio : (As of Apr. 10, 2026) - GuruFocus
Who's Buying or Selling Bruker Corp (BSP:B2RK34) Stock Today? - GuruFocus
Bruker Corp Stock Operating Data - GuruFocus
Bruker Corp (BSP:B2RK34) Competitors 2026 - GuruFocus
Bruker Corp (BSP:B2RK34) Stock Earnings Transcripts - GuruFocus
Bruker Corp (BSP:B2RK34) Stock Price & 30 Year Financial Data - GuruFocus
Bruker Corp (BSP:B2RK34) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Bruker Corp (BSP:B2RK34) Dividend - GuruFocus
Bruker Corp (BSP:B2RK34) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Bruker Corp Stock Baskets - GuruFocus
Bruker Corp (BSP:B2RK34) DCF Valuation - GuruFocus
Bruker Corp (BSP:B2RK34)Valuation Measures & Financial Statistics - GuruFocus
Bruker Corp Stock (BRKR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Bruker Corp Stock (BRKR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Apr 15 '26 |
Sale |
39.90 |
2,000 |
79,800 |
128,443 |
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):